ICHRMEDIUM SIGNALFINANCIAL10-K

ICHR reduced share buybacks dramatically while growing revenue modestly, though profitability declined and interest costs rose substantially.

The near-elimination of share buybacks suggests either reduced cash availability or a strategic shift in capital allocation priorities. Combined with rising interest expense and declining gross margins, this indicates potential operational challenges despite top-line growth.

Comparing 2026-02-20 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

Revenue grew modestly to $947.7 million while gross profit declined to $87.8 million, indicating margin compression. Interest expense rose substantially to $19.4 million and SG&A expenses increased to $95.7 million, pressuring profitability. The dramatic reduction in share buybacks from $90.0 million to $1.6 million signals a significant shift in capital allocation strategy, potentially reflecting cash flow constraints or management's focus on debt reduction given the higher interest costs.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-98.2%
$90.0M$1.6M

Buyback activity reduced 98.2% — capital being redeployed elsewhere or cash conservation underway.

Interest Expense
P&L
+75.3%
$11.1M$19.4M

Interest expense surged 75.3% — significant debt increase or rising rates materially impacting earnings.

SG&A Expense
P&L
+20.5%
$79.4M$95.7M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Accounts Receivable
Balance Sheet
-18.6%
$86.6M$70.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Gross Profit
P&L
-15.1%
$103.3M$87.8M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Revenue
P&L
+11.6%
$849.0M$947.7M

Revenue growing 11.6% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-20
PRIOR — 2025-02-21
ADDED
The aggregate market value of voting ordinary shares held by non-affiliates of the registrant was $ 658,256,416 based on the closing price of the ordinary shares as reported on The Nasdaq Global Select Market as of June 27, 2025, the last business day of the registrant's most recently completed second fiscal quarter.
Management s Discussion and Analysis of Financial Condition and Results of Operations .
We also provide precision-machined components, weldments, e-beam and laser welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products.
Most OEMs outsource all or a portion of the design, engineering, and manufacturing of their gas delivery subsystems to a few specialized suppliers, including us.
Outsourcing enables OEMs to reduce their costs and development time, as well as provide growth opportunities for specialized subsystems suppliers like us.
+7 more — sign up free →
REMOVED
The aggregate market value of voting ordinary shares held by non-affiliates of the registrant was $ 1,280,861,000 based on the closing price of the ordinary shares as reported on The Nasdaq Global Select Market as of June 28, 2024, the last business day of the registrant's most recently completed second fiscal quarter.
Management s Discussion and Analysis of Financial Condition and Results of Operations.
We also provide precision-machined components, weldments, electron beam ( e beam ) and laser-welded components, precision vacuum and hydrogen brazing and surface treatment technologies, and other proprietary products for the commercial space, aerospace, defense, medical device, and general-industrial industries.
This vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems, respectively.
Most original equipment manufacturers ( OEMs ) outsource all or a portion of the design, engineering, and manufacturing of their gas delivery subsystems to a few specialized suppliers, including us.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →